Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Pancreas CancerLocally AdvancedLocally Advanced Pancreatic Adenocarcinoma
Interventions
RADIATION

Stereotactic Ablative Body Radiation (SABR)

50 Gy in 5 fractions, once per day for 5 days

DEVICE

Tumor Treating Fields (TTF)

Participant will use the system for at least 18 hours per day starting on the first day of SABR until abdominal disease progression. Short treatment breaks are permitted for personal needs (such as to take a shower) and during radiation therapy. An additional treatment break is permitted for up to 48 hours every 21 days.

Trial Locations (1)

33176

RECRUITING

Miami Cancer Institute at Baptist Health, Inc., Miami

All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

lead

Baptist Health South Florida

OTHER